Further assessment and analysis of the SARS-CoV-2-specific T-cell memory at 4 M revealed the enhanced IFNγ+CD4+ and CD8+ memory T cell responses (Supplementary Fig. 1b) with increasing in the initial COVID-19 severity from mild to moderate to severe (Fig. 5a, b). The gene discussed is CD8A; the disease is COVID-19.